Search

Displaying results 7901 - 7910 of 10000 in total
  1. Drug

    Hydrocortisone cypionate

    go.drugbank.com/drugs/DB14541
    ApprovedVet approvedWithdrawn

  2. Indication

    Cyclitis

    go.drugbank.com/conditions/DBCOND0009942
    Drugs: Clobetasone · Loteprednol · Prednisolone
    Synonyms: Cyclitis, NOS
  3. Indication

    Coccidioidomycosis

    go.drugbank.com/conditions/DBCOND0000138
    Drugs: Amphotericin B · Fluconazole · Ketoconazole · Posaconazole · Voriconazole
    Synonyms: Coccidioidomycosis, NOS, Coccidioidomycosis NOS (disorder)
  4. Indication

    Plaque, Dental

    go.drugbank.com/conditions/DBCOND0092704
    Drugs: Benzamidine · Chlorhexidine · Sodium bicarbonate · Thymol · Triclosan
    Synonyms: Patch, NOS, Plaque, NOS
  5. Indication

    Toxoplasmosis

    go.drugbank.com/conditions/DBCOND0013910
    Drugs: Acetyl sulfisoxazole · Clindamycin · Pyrimethamine
    Synonyms: Toxoplasmosis NOS, Toxoplasmosis NOS (disorder)
  6. Drug

    Ketodarolutamide

    go.drugbank.com/drugs/DB15647
    Experimental

    Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of darolutamide.

    Categories: Antiandrogens, non-steroidal
  7. Drug

    ARX201

    go.drugbank.com/drugs/DB05082
    Investigational

    human growth hormone that has been modified using Ambrx’s patented ReCODE™ technology to achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth hormone, by

  8. Drug

    Carfilzomib

    go.drugbank.com/drugs/DB08889
    ApprovedInvestigational

    Carfilzomib is an injectable antineoplastic agent (IV only). Chemically, it is a modified tetrapeptidyl epoxide and an analog of epoxomicin. It is also a selective proteasome inhibitor. FDA approved carfilzomib in July 2012 for the treat...

  9. Drug

    Dihydrotachysterol

    go.drugbank.com/drugs/DB01070
    ApprovedWithdrawn

    A vitamin D that can be regarded as a reduction product of vitamin D2.

  10. Drug

    Asciminib

    go.drugbank.com/drugs/DB12597
    ApprovedInvestigational

    Asciminib is a tyrosine kinase inhibitor (TKI) used in the treatment of chronic-phase Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). More specifically, it is an inhibitor of the ABL1 kinase activity of the BCR-ABL1 ...